The Inception Companies appointed Matt Giegerich, longtime CEO of WPP’s Ogilvy CommonHealth, to serve as CEO for Inception’s two largest business units.
Brenda L. Raphael was appointed senior VP and general manager of Bayer’s Therapeutics Business Unit of Consumer Health Commercial Operations North America. Jennifer Brendel was named VP of communications for Bayer’s Consumer Health Division in the United States.
Astellas promoted two executives into new roles. Nate Crisel is now VP, Real World Informatics & Analytics (RWI), at Astellas, reporting to Chikashi Takeda, chief financial officer. Gary Thal, M.D., was promoted to VP, Specialty, Medical Affairs, Americas, reporting to Shontelle Dodson, PharmD., senior VP, Medical Affairs, Americas.
Robert Truckenmiller was tapped as senior VP, Market Access & Customer Solution
Karen Reeves, M.D., was appointed by AZTherapies as president and chief medical officer.
Diego Miralles, M.D., was named CEO of Vividion Therapeutics Inc.
Dominique P. Monnet was appointed to the position of president of PDL BioPharma Inc.
One Drop, a digital diabetes care and self-management platform, announced a multi-part collaboration with Fitbit that will use the power of Fitbit wearable data to bring enhanced data-driven care management tools to the diabetes community.
Takeda Pharmaceuticals U.S.A. Inc., Lundbeck U.S., and Advocate Health Care announced a collaboration focusing on the use of digital technology to support people living with depression.
A DRG Digital – Manhattan Research study of 189 U.S. P&T committee members making formulary decisions at hospitals, IDNs, PBMs, MCOs and ACOs found that on average, these key professionals spend upwards of three hours per day using digital resources to inform their committee work.
